Our Global Cancer Program joined international collaborators at the African Organisation for Research and Training in Cancer (AORTIC) conference in Tunisia.
He was told cancer would kill him in two to four years. Fourteen years later, he credits a series of medications and treatments funded by the National Institutes of Health.
Innovative research was presented by experts from the UCSF Department of Urology at the Western Section of the American Urological Association’s SurgeWest 2025
UC San Francisco researchers and clinicians presented innovative research and treatment strategies at the American Society of Radiation Oncology’s 2025 Annual Meeting in San Francisco.
David Raleigh, MD, PhD, is a radiation oncologist whose work focuses on understanding links between meningioma and the synthetic progesterone MPA that’s used in injectable birth control.
In September, our Office of Education and Training coordinated a Cancer Research Showcase for Graduate Students, designed to introduce the vibrant cancer research community at UCSF to students across PhD and MD/PhD programs who wish to pursue a degree in cancer biology.
Researchers from UC San Francisco, have discovered that a novel combination of immunotherapies can reprogram the immune environment of colon cancer tumors that spread to the liver.
Matching grant from Weill family creates collaborative research hub, uniting scientists from UCSF and Stanford Medicine to transform cancer care within a decade.